Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of PPSV23 Revaccination in Elderly with Diabetes vs Healthy
NCT04875858Phase 4Unknown
- Sponsor
- Korea University Guro Hospital
- Start
- May 2021
- Primary completion
- Apr 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of ProDiax-23 in pneumococcal infection, sponsored by Korea University Guro Hospital. Status: unknown.
02
Drugs
ProDiax-23
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT04875858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04875858.